Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids (Q46730792)

From Wikidata
Jump to navigation Jump to search
scientific article
  • Impact of genetic polymorphisms inCYP2C8and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids
edit
Language Label Description Also known as
English
Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids
scientific article
  • Impact of genetic polymorphisms inCYP2C8and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids

Statements

Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit